Puneet S. Arora - Feb 24, 2025 Form 4 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Chief Medical Officer
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Stock symbol
SKYE
Transactions as of
Feb 24, 2025
Transactions value $
$0
Form type
4
Date filed
2/26/2025, 05:34 PM
Previous filing
Sep 4, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SKYE Stock Option (Right to Buy) Award $0 +38K $0.00 38K Feb 24, 2025 Common Stock 38K $2.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests 25% on the one year anniversary of February 21, 2025 and 1/48th monthly thereafter.